-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GVqMkSwBwrkxoaYoB9te+BfsD5XQvMXIukWRS/aM/NJyj2zLw6eTkZMBxjVXo0J1 a+NFoBH3x2P/XDdRkjSJuA== 0000943663-07-000631.txt : 20071210 0000943663-07-000631.hdr.sgml : 20071210 20071210172831 ACCESSION NUMBER: 0000943663-07-000631 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071210 DATE AS OF CHANGE: 20071210 GROUP MEMBERS: EL CORONADO HOLDINGS LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACOPEIA INC CENTRAL INDEX KEY: 0001273013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 510418085 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-79837 FILM NUMBER: 071296680 BUSINESS ADDRESS: STREET 1: P.O. BOX 5350 CITY: PRINCETON STATE: NJ ZIP: 08543-5350 BUSINESS PHONE: 609-452-3600 MAIL ADDRESS: STREET 1: P.O. BOX 5350 CITY: PRINCETON STATE: NJ ZIP: 08543-5350 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACOPEIA DRUG DISCOVERY INC DATE OF NAME CHANGE: 20031212 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AUSTIN JOSIAH T CENTRAL INDEX KEY: 0000932267 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: EL CORANADO RANCH STREET 2: STAR ROUTE BOX 395 CITY: PEARCE STATE: AZ ZIP: 85625 BUSINESS PHONE: 214-520-1684 MAIL ADDRESS: STREET 1: 4673 CHRISTOPHER PLACE CITY: DALLAS STATE: TX ZIP: 75204 SC 13D 1 austininitial13dpcop.htm SCHEDULE 13D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

 

 

PHARMACOPEIA, INC.

____________________________________________________________________________________

(Name of Issuer)

 

 

Common Stock, $0.01 par value

____________________________________________________________________________________

(Title of Class of Securities)

 

 

7171EP101

_______________________________________________________

(CUSIP Number)

 

 

David J. Harris, Esq., 1775 Eye Street, N.W. Washington, D.C. 20006 (202) 261-3385

____________________________________________________________________________________

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

 

November 28, 2007

______________________________________________________

(Date of Event which Requires Filing of this Statement)

 

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


 

1

NAME OF REPORTING PERSON

Josiah T. Austin

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X]

3

SEC USE ONLY

 

4

SOURCE OF FUNDS

OO

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

 

66,900 Shares

8

SHARED VOTING POWER

 

1,800,151 Shares

9

SOLE DISPOSITIVE POWER

 

66,900 Shares

10

SHARED DISPOSITIVE POWER

 

1,800,151 Shares

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,867,051 Shares

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES) [ ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

6.3%

14

TYPE OF REPORTING PERSON

 

IN

 

1

NAME OF REPORTING PERSON

 

El Coronado Holdings, L.L.C.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                  (a) [ ] (b) [X]

3

SEC USE ONLY

4

SOURCE OF FUNDS

 

WC

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Arizona

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

 

Not Applicable

8

SHARED VOTING POWER

 

1,800,151 Shares

9

SOLE DISPOSITIVE POWER

 

Not applicable

10

SHARED DISPOSITIVE POWER

 

1,800,151 Shares

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,800,151 Shares

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

6.08%

14

TYPE OF REPORTING PERSON

 

HC


 

Item 1.

Security and Issuer

     
 

This statement refers to the common stock, $0.01 par value ("Common Stock"), of Pharmacopeia, Inc. (the "Company"). The address of the Company is PO Box 5350, Princeton, New Jersey 08543-5350.

     

Item 2.

Identity and Background

 
     
 

This statement is being filed on behalf of Josiah T. Austin ("Austin"), a U.S. citizen, and El Coronado Holdings, LLC ("ECH") an Arizona limited liability company (collectively the "Reporting Persons").

     

Further information regarding the identity and background of the Reporting Persons is as follows:

     
 

For Austin:

     
 

(a)

Josiah T. Austin;

     
 

(b)

4673 Christopher Place, Dallas, Texas 75204;

     
 

(c)

Present principal occupation: individual investor.

     
 

For ECH:

     
 

(a)

El Coronado Holdings, L.L.C.;

     
 

(b)

4673 Christopher Place, Dallas, Texas 75204;

     
 

(c)

Holding Company;

     
 

(d)-(e)

During the last five years, none of the Reporting Persons nor, to the best of the knowledge of the Reporting Persons, the members or controlling persons of any Reporting Person have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.

   

Item 3.

Source and Amount of Funds or Other Consideration

     
 

(1)

Acting on behalf of ECH, Austin purchased from December 27, 2006 to November 30, 2007 a total of 1,800,151 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $8,843,489.76. The primary source of funds for these purchases was existing funds of ECH.

     
 

(2)

Acting on behalf of the Josiah & Valer Austin Family Revocable Trust, in his capacity as Trustee, Austin purchased from February 27, 2007 to July 10, 2007 a total of 49,300 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $263,719.39. The primary source of funds for these purchases was existing funds of the Trust.

     
 

(3)

Acting on behalf of the Anna Lake Elias Trust dated 4/6/06, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 1,500 shares of Common Stock in an open market transaction for an aggregate consideration (exclusive of brokers' commissions) of $7,125. The primary source of funds for this purchase was existing funds of the Trust.

     
 

(4)

Acting on behalf of the Josiah Zane Sylvester 2006 Grandchild Gift Trust, in his capacity as Trustee, Austin purchased from February 27, 2007 to July 11, 2007 a total of 1,500 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $7,636.45. The primary source of funds for these purchases was existing funds of the Trust.

     
 

(5)

Acting on behalf of the Josiah Zane Sylvester Trust Under AZ Uniform TFRS to Minors Act, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 400 shares of Common Stock in an open market transaction for an aggregate consideration (exclusive of brokers' commissions) of $1,900. The primary source of funds for this purchase was existing funds of the Trust.

     
 

(6)

Acting on behalf of the Jackson Austin Lowery 2006 Grandchild Gift Trust, in his capacity as Trustee, Austin purchased from February 27, 2007 to July 11, 2007 a total of 1,500 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $7,636.45. The primary source of funds for these purchases was existing funds of the Trust.

     
 

(7)

Acting on behalf of the Austin-Clark Family Irrevocable Life Insurance Trust dated 11/6/1990, in his capacity as Trustee, Austin purchased from February 28, 2007 to March 1, 2007 a total of 10,000 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $46,579. The primary source of funds for these purchases was existing funds of the Trust.

     
 

(8)

Acting on behalf of the Anna Lake Elias Trust Under AZ Uniform TFRS to Minors Act, in his capacity as Trustee, Austin purchased from February 27, 2007 to July 10, 2007 a total of 1,200 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $6,434.86. The primary source of funds for these purchases was existing funds of the Trust.

     
 

(9)

Acting on behalf of the Mary Kathleen Lowery 2006 Grandchild Gift Trust, in his capacity as Trustee, Austin purchased from April 12, 2007 to July 11, 2007 a total of 1,500 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $9,106.45. The primary source of funds for these purchases was existing funds of the Trust.

     
 

All dollar amounts are in U.S. dollars.

   

Item 4.

Purpose of Transaction

   
 

The acquisitions of common stock to which this statement relates have been made for investment purposes. Austin, as sole Managing Member of ECH, will continually evaluate the business, financial conditions, and prospects of the Company, as well as conditions in the economy and the pharmaceutical industry in general, with a view toward determining whether to hold, decrease, or add to these investments in common stock.

     

Item 5.

Interest in Securities of the Issuer

     
 

(a)

Austin is deemed beneficial owner of 1,867,051 shares of Common Stock in his capacity as Trustee for certain family trusts and as sole Managing Member of ECH. ECH is deemed beneficial owner of 1,800,151 shares of Common Stock. Based on the 29,615,353 shares of Common Stock outstanding as of October 31, 2007, as reported in the Company's 10-Q filed on November 5, 2007, Austin and ECH's deemed beneficial holdings represent, respectively, 6.3% and 6.08% of the Company's Common Stock.

     
 

(b)

As Trustee for certain family trusts, Austin has the sole power to vote or to dispose or direct the disposition of 66,900 shares of Common Stock. As sole Managing Member of ECH, Austin shares with ECH the power to vote or dispose or to direct the disposition of 1,800,151 shares of Common Stock.

     
 

(c)

No transactions in the Company's Common Stock have been effected by the Reporting Persons during the last 60 days except the following transactions, each of which was made in a broker's transaction in the open market. Prices do not include brokerage fees.

     

Reporting Person

Date

No. of Shares

Price Per Share

ECH

11/26/07

15,000

$4.4833

ECH

11/27/07

30,000

$4.49

ECH

11/28/07

115,750

$4.476

ECH

11/29/07

125,000

$4.5072

ECH

11/30/07

214,250

$4.5401

     
 

(d)

No person other than the Reporting Persons has any right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities.

     
 

(e)

Not Applicable.

     

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to the Issuer

     
 

There are no contracts, arrangements, understandings or relationships (legal or otherwise) between ECH, Austin and any person with respect to any securities of the Company.

     

Item 7.

Materials to Be Filed as Exhibits

     
 

None.


 

SIGNATURE

 

After reasonable inquiry and to the best knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

 

 

Date: December 10, 2007

/s/ Josiah T. Austin

 

Josiah T. Austin,

 

Individually and as Sole Managing Member of ECH

-----END PRIVACY-ENHANCED MESSAGE-----